Monday, December 28, 2015 9:25:03 AM
On December 27, 2015, Tom Fernandez and Marek Biestek resigned as members of the board of directors (the “Board”) of KaloBios Pharmaceuticals, Inc. (the “Company”). There were no disagreements with the Company that led to the resignations.
Item 5.03. Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year.
On December 27, 2015, the Board approved an amendment to the Company’s Amended and Restated Bylaws to provide a procedure for the Board to fix a record date for the determination of stockholders entitled to participate in certain corporate actions, including, among others, to express consent to corporate action in writing without a meeting.
The foregoing description of the amendment to the Amended and Restated Bylaws does not purport to be a complete statement of the provisions thereof. Such description is qualified in its entirety by reference to the amendment, a copy of which is included as Exhibit 3.2 to this Form 8-K and is incorporated herein by reference thereto.
Click For Link
Blessings to All
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM